Mebendazol ratiopharm

Mebendazol ratiopharm may be available in the countries listed below.

Ingredient matches for Mebendazol ratiopharm

Mebendazole

Mebendazole is reported as an ingredient of Mebendazol ratiopharm in the following countries:

• Netherlands

International Drug Name Search

Prostin VR Pediatric

Prostin VR Pediatric is a brand name of alprostadil, approved by the FDA in the following formulation(s):

PROSTIN VR PEDIATRIC (alprostadil - injectable; injection)

• 
  Manufacturer: PHARMACIA AND UPJOHN
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 0.5MG/ML ^[RLD][AP]

Has a generic version of Prostin VR Pediatric been approved?

Yes. The following products are equivalent to Prostin VR Pediatric:

alprostadil injectable; injection

• 
  Manufacturer: BEDFORD
  
  Approval date: January 20, 1998
  
  Strength(s): 0.5MG/ML ^[AP]


• 
  Manufacturer: TEVA PARENTERAL
  
  Approval date: April 30, 1999
  
  Strength(s): 0.5MG/ML ^[AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Prostin VR Pediatric. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Prostin VR Pediatric.

See also...

• Prostin VR Pediatric injectable and transurethral Consumer Information (Cerner Multum)
• Prostin VR Pediatric Advanced Consumer Information (Micromedex)
• Alprostadil Consumer Information (Wolters Kluwer)
• Alprostadil Suppository Consumer Information (Wolters Kluwer)
• Alprostadil injectable and transurethral Consumer Information (Cerner Multum)
• Muse Micro Advanced Consumer Information (Micromedex)
• Alprostadil Intraurethral, Intravenous, Intracavernosal Advanced Consumer Information (Micromedex)
• Alprostadil AHFS DI Monographs (ASHP)

Xalcom

Xalcom may be available in the countries listed below.

Ingredient matches for Xalcom

Latanoprost

Latanoprost is reported as an ingredient of Xalcom in the following countries:

• Denmark


• Norway


• Sweden

Timolol

Timolol maleate (a derivative of Timolol) is reported as an ingredient of Xalcom in the following countries:

• Denmark


• Iceland


• Norway


• Sweden

International Drug Name Search

Cleviprex

Cleviprex is a brand name of clevidipine, approved by the FDA in the following formulation(s):

CLEVIPREX (clevidipine butyrate - emulsion; intravenous)

• 
  Manufacturer: MEDICINES CO
  
  Approval date: August 1, 2008
  
  Strength(s): 25MG/50ML (0.5MG/ML) ^[RLD], 50MG/100ML (0.5MG/ML) ^[RLD]

Has a generic version of Cleviprex been approved?

No. There is currently no therapeutically equivalent version of Cleviprex available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cleviprex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Pharmaceutical emulsion
  Patent 5,739,152
  Issued: April 14, 1998
  Inventor(s): Andersson; Kjell Hjalmar & Byrod; Eva Kristina & Hansson; Anna-Carin & Nordlander; Margareta & Westerlund; Rolf Christer
  Assignee(s): Astra Aktiebolag
  A pharmaceutical emulsion for intravenous administration is disclosed which comprises a) a short acting dihydropyridine compound; b) a lipid phase; c) an emulsifier and d) water or a buffer.
  
  Patent expiration dates:
  
  
  • April 14, 2015
    
    ✓ 
    Patent use: CLEVIPREX IS A DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKER INDICATED FOR THE REDUCTION OF BLOOD PRESSURE WHEN ORAL THERAPY IS NOT FEASIBLE OR NOT DESIRABLE
    ✓ 
    Drug product
  
  



• 
  Short-acting dihydropyridines
  Patent 5,856,346
  Issued: January 5, 1999
  Inventor(s): Andersson; Kjell Hjalmar & Nordlander; Margareta & Westerlund; Rolf Christer
  Assignee(s): Astra Aktiebolag
  Compounds of the general formula ##STR1## wherein R.sub.1 and R.sub.2 are independently selected from the group consisting of hydrogen, chloro, bromo, nitro, cyano, trifluoromethyl, and R.sub.3 and R.sub.4 are independently selected from straight or branched lower (1-5 carbon atoms) alkyl groups, and including all optical isomers, provided that when R.sub.3 is methyl and R.sub.4 is tert.-butyl, then R.sub.1 /R.sub.2 are not hydrogen/hydrogen, hydrogen/2'-trifluormethyl, 2'-chloro/3'-chloro, and when R.sub.3 is methyl and R.sub.1 /R.sub.2 is hydrogen/3'-nitro, then R.sub.4 are not methyl, ethyl, propyl, iso-propyl, tert.-butyl, processes for their preparation, pharmaceutical preparations containing them and the use of the compounds in lowering the blood pressure.
  
  Patent expiration dates:
  
  
  • January 5, 2016
    
    ✓ 
    Patent use: CLEVIPREX IS A DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKER INDICATED FOR THE REDUCTION OF BLOOD PRESSURE WHEN ORAL THERAPY IS NOT FEASIBLE OR NOT DESIRABLE
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • August 1, 2013 - NEW CHEMICAL ENTITY
  
  

See also...

• Cleviprex Consumer Information (Drugs.com)
• Cleviprex Consumer Information (Wolters Kluwer)
• Cleviprex Consumer Information (Cerner Multum)
• Cleviprex Advanced Consumer Information (Micromedex)
• Clevidipine Consumer Information (Wolters Kluwer)
• Clevidipine Consumer Information (Cerner Multum)
• Clevidipine Intravenous Advanced Consumer Information (Micromedex)

Amoxicilline Médiphasante

Amoxicilline Médiphasante may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Amoxicilline Médiphasante

Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicilline Médiphasante in the following countries:

• France

International Drug Name Search

Doxazosin Uro Hexal

Doxazosin Uro Hexal may be available in the countries listed below.

Ingredient matches for Doxazosin Uro Hexal

Doxazosin

Doxazosin mesilate (a derivative of Doxazosin) is reported as an ingredient of Doxazosin Uro Hexal in the following countries:

• Germany

International Drug Name Search

Alendronate Ratiopharm

Alendronate Ratiopharm may be available in the countries listed below.

Ingredient matches for Alendronate Ratiopharm

Alendronic Acid

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Alendronate Ratiopharm in the following countries:

• Belgium

International Drug Name Search

Anxiolan

Anxiolan may be available in the countries listed below.

Ingredient matches for Anxiolan

Buspirone

Buspirone hydrochloride (a derivative of Buspirone) is reported as an ingredient of Anxiolan in the following countries:

• Thailand

International Drug Name Search

Amoxicilline / Acide Clavulanique Zydus

Amoxicilline/Acide Clavulanique Zydus may be available in the countries listed below.

Ingredient matches for Amoxicilline/Acide Clavulanique Zydus

Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicilline/Acide Clavulanique Zydus in the following countries:

• France

Clavulanate

Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Amoxicilline/Acide Clavulanique Zydus in the following countries:

• France

International Drug Name Search

Methylprednisolon AL

Methylprednisolon AL may be available in the countries listed below.

Ingredient matches for Methylprednisolon AL

Methylprednisolone

Methylprednisolone is reported as an ingredient of Methylprednisolon AL in the following countries:

• Germany

International Drug Name Search

Fudesix

Fudesix may be available in the countries listed below.

Ingredient matches for Fudesix

Furosemide

Furosemide is reported as an ingredient of Fudesix in the following countries:

• Greece

International Drug Name Search

Acarbose-CT

Acarbose-CT may be available in the countries listed below.

Ingredient matches for Acarbose-CT

Acarbose

Acarbose is reported as an ingredient of Acarbose-CT in the following countries:

• Germany

International Drug Name Search

Paracetamol Grindeks

Paracetamol Grindeks may be available in the countries listed below.

Ingredient matches for Paracetamol Grindeks

Paracetamol

Paracetamol is reported as an ingredient of Paracetamol Grindeks in the following countries:

• Estonia


• Latvia

International Drug Name Search